A detailed history of Macquarie Group LTD transactions in Medpace Holdings, Inc. stock. As of the latest transaction made, Macquarie Group LTD holds 41,184 shares of MEDP stock, worth $16.6 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
41,184
Previous 41,173 0.03%
Holding current value
$16.6 Million
Previous $12.6 Million 31.89%
% of portfolio
0.02%
Previous 0.01%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

BUY
$284.87 - $413.31 $3,133 - $4,546
11 Added 0.03%
41,184 $16.6 Million
Q4 2023

Feb 14, 2024

BUY
$227.52 - $312.68 $4.76 Million - $6.54 Million
20,901 Added 103.1%
41,173 $12.6 Million
Q3 2023

Nov 14, 2023

SELL
$233.98 - $281.67 $917,435 - $1.1 Million
-3,921 Reduced 16.21%
20,272 $4.91 Million
Q2 2023

Aug 14, 2023

BUY
$187.26 - $240.17 $4.53 Million - $5.81 Million
24,193 New
24,193 $5.81 Million
Q3 2022

Nov 14, 2022

SELL
$145.13 - $182.49 $54,714 - $68,798
-377 Reduced 39.94%
567 $148,000
Q1 2021

May 14, 2021

SELL
$132.02 - $168.26 $83,304 - $106,172
-631 Reduced 40.06%
944 $155,000
Q2 2020

Aug 11, 2020

SELL
$68.08 - $95.68 $62,974 - $88,504
-925 Reduced 37.0%
1,575 $147,000
Q3 2019

Nov 14, 2019

SELL
$62.38 - $85.89 $162,188 - $223,314
-2,600 Reduced 50.98%
2,500 $210,000
Q2 2019

Aug 14, 2019

BUY
$53.64 - $65.42 $273,564 - $333,642
5,100 New
5,100 $334,000
Q1 2019

May 15, 2019

SELL
$49.38 - $70.58 $49,380 - $70,580
-1,000 Closed
0 $0
Q4 2018

Feb 15, 2019

SELL
$46.97 - $63.98 $14,091 - $19,194
-300 Reduced 23.08%
1,000 $53,000
Q3 2018

Nov 15, 2018

SELL
$43.25 - $63.74 $289,775 - $427,058
-6,700 Reduced 83.75%
1,300 $78,000
Q2 2018

Aug 14, 2018

BUY
$34.03 - $45.46 $156,538 - $209,116
4,600 Added 135.29%
8,000 $344,000
Q1 2018

May 11, 2018

BUY
$32.03 - $39.05 $108,902 - $132,770
3,400 New
3,400 $119,000

Others Institutions Holding MEDP

About Medpace Holdings, Inc.


  • Ticker MEDP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 31,099,900
  • Market Cap $12.5B
  • Description
  • Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...
More about MEDP
Track This Portfolio

Track Macquarie Group LTD Portfolio

Follow Macquarie Group LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Macquarie Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Macquarie Group LTD with notifications on news.